440662-09-9
440662-09-9 structure
- Name: CeMMEC1
- Chemical Name: N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-methyl-1-oxo-1,2-dihydro-4-isoquinolinecarboxamide
- CAS Number: 440662-09-9
- Molecular Formula: C19H16N2O4
- Molecular Weight: 336.341
- Catalog: Signaling Pathways Cell Cycle/DNA Damage DNA/RNA Synthesis
- Create Date: 2018-02-26 15:04:40
- Modify Date: 2024-01-07 22:31:52
-
CeMMEC1 is an inhibitor of BRD4, and also has high affinity for TAF1, with an IC50 of 0.9 μM for TAF1, and a Kd of 1.8 μM for TAF1 (2).
| Name | N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-methyl-1-oxo-1,2-dihydro-4-isoquinolinecarboxamide |
|---|---|
| Synonyms |
N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-methyl-1-oxo-1,2-dihydro-4-isoquinolinecarboxamide
4-Isoquinolinecarboxamide, N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,2-dihydro-2-methyl-1-oxo- CeMMEC1 |
| Description | CeMMEC1 is an inhibitor of BRD4, and also has high affinity for TAF1, with an IC50 of 0.9 μM for TAF1, and a Kd of 1.8 μM for TAF1 (2). |
|---|---|
| Related Catalog | |
| Target |
Kd: 1.8 μM (TAF1 (2))[1] IC50: 0.9 μM (TAF1)[1] |
| In Vitro | CeMMEC1 is an inhibitor of BRD4, and also has high affinity for TAF1, with an IC50 of 0.9 μM for TAF1, and a Kd of 1.8 μM for TAF1 (2) and slso shows high affinity for the bromodomains of CREBBP, EP300, BRD9. CeMMEC1 (1, 10, 20 μM) decreases the number of THP1 cells in S phase in a dose manner. CeMMEC1 also induces apoptosis. CeMMEC1 in combination with (S)-JQ1 displays potently impaired cell viability than treatment alone[1]. |
| Kinase Assay | TAF1 binding assays are conducted using the EPIgeneous Binding Domain kit B. Binding is determined by the displacement of an acetylated biotin peptide from a GST-tagged TAF1 protein using HTRF with a Eu3+-conjugated GST antibody donor and streptavidin-conjugated acceptor. Compounds (CeMMEC1) are dispensed into assay plates, ProxiPlate-384 Plus using an Echo 525 Liquid Handler. Binding assays are conducted in a final volume of 20 μL with 5 nM TAF1-GST, 50 nM peptide (SGRGK (ac)GGK (ac)GLGK (ac)GGAK (ac)RHRK (biotin)-acid), 6.25 nM Streptavidin-XL665, 1:200 Anti-GST-Eu3+ cryptate and 0.1% DMSO. Assay reagents are dispensed into plates using a Multidrop combi and incubated at room temperature for 3 h. Fluorescence is measured using a PHERAstar microplate reader using the HTRF module with dual emission protocol (A = excitation of 320 nm, emmission of 665 nm, and B = excitation of 320 nm, emission of 620 nm). Raw data are processed to give an HTRF ratio (channel A/B × 10,000), which is used to generate IC50 curves[1]. |
| Cell Assay | Cells are seeded on clear flat-bottom 96-well or 384-well plates and treated with the indicated compounds (CeMMEC1) for the specified conditions. Live-cell imaging pictures are taken with the Operetta High Content Screening System, 20× objective and nonconfocal mode[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 590.1±50.0 °C at 760 mmHg |
| Molecular Formula | C19H16N2O4 |
| Molecular Weight | 336.341 |
| Flash Point | 310.7±30.1 °C |
| Exact Mass | 336.110992 |
| LogP | 2.69 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.673 |
| Storage condition | -20℃ |